menu
GlobalMicroRNA (miRNA) Market
GlobalMicroRNA (miRNA) Market was valued US$ xx Mn in 2019 and is expected togrow US$ xx Mn by 2027, at a CAGR of 13.55% during the forecast period.

 

GlobalMicroRNA (miRNA) Market was valued US$ xx Mn in 2019 and is expected togrow US$ xx Mn by 2027, at a CAGR of 13.55% during the forecast period.

 

 

 

Global MicroRNA (miRNA) Market

 

To know about the Research Methodology :- Request FreeSample Report

 

The report has analyzed the revenue impact of the COVID-19pandemic on the sales revenue of market leaders, market followers, and marketdisrupters in the report, and the same is reflected in our analysis.

 

MicroRNA, also recognized as miRNA. It is a class of RNAthat plays a vital role in the regulation of gene expression and is alsoinvolved in RNA silencing. MicroRNA is found in animals, plants, and someviruses. Generally, the development of well-organized and advanced technology,rise in consciousness, increasing focus on R&D, growing governmentinitiative across the globe, development of molecular biology and genomictechnologies, and growing government’s funding on healthcare are the majorgrowth drivers of the global micro-RNA market.

 

Growing number of patients suffering from cancer and othercardiovascular disorders, rising number of therapeutic applications, increasingadoption of the technology for use, reducing the cost of the sequencing aresome of the factors which are driving the growth of the MicroRNA (miRNA) marketin oncology in the forecast period (2019-2027). As well as, an increase in theadoption of micro-RNA in developing economies like China, India, and others,will create new opportunities for the global micro-RNA market.

 

The high cost of kits and products with a lack of enhancedinfrastructure are the restraints for the market growth of the MicroRNA (miRNA)market in oncology in the forecast period. The growing demand for skilled personnelalong with challenges concerning in-house development of analysis which is thekey challenge for the growth of the micro-RNA market.

 

Existence of several companies, particularly domesticplayers creating massive price competition. Thermo Fisher Scientific Inc. isthe leader in the global microRNA market in terms of revenue share in 2018,because of a varied product portfolio. Thermo Fisher Scientific Inc. alsooffers microRNA products exactly catering to the animal health and agriculturesegment. Hence its wide product range providing to different end-users make ita market leader in the microRNA market. Illumina Inc., takings second positionin the global microRNA market. The company has microarray kits and librarypreparation kits for miRNA.

 

By End-use, Academic & government research institutesheld the largest market share in the global market in 2018. This is mainlybecause of the rapid adoption of microRNA research tools by universities andresearch labs. The biotech & pharma companies segment is poised to post thehighest CAGR in the forecast period, on account of the rapid adoption ofresearch tools in the translation of scientific knowledge to clinicalapplication.

 

By region, North America held the largest market share ofthe global market in 2019, with approximately half of the world’s proceduresbeing done in the U.S. because of high medical reimbursement facilities,support from the government, and technological advancement. Asia Pacificmicro-RNA market is expected to grow with a significant pace, because of thefast increasing population, rise in consumer awareness, favorable governmentpolicies, modernization of healthcare infrastructure, and upward investments bythe foreign countries in emerging countries such as China, and India in the APACregion.

 

As well as, remarkable progress in genomic studies and therising adoption of innovative technologies are expected to encourage the growthof the Asia Pacific market. For example, TaKaRa Bio, are involved in thedevelopment of products that consist of arrays and kits, so improving thegrowth of the APAC region.

 

The objective of the report is to present a comprehensiveanalysis of the Global MicroRNA (miRNA) Market including all the stakeholdersof the industry. The past and current status of the industry with forecastedmarket size and trends are presented in the report with the analysis ofcomplicated data in simple language. The report covers all the aspects of theindustry with a dedicated study of key players that includes market leaders, followers,and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact ofmicro-economic factors of the market have been presented in the report.External as well as internal factors that are supposed to affect the businesspositively or negatively have been analyzed, which will give a clear futuristicview of the industry to the decision-makers.

The report also helps in understanding Global MicroRNA(miRNA) Market dynamics, structure by analyzing the market segments and projectthe Global MicroRNA (miRNA) Market size. Clear representation of competitiveanalysis of key players by type, price, financial position, product portfolio,growth strategies, and regional presence in the Global MicroRNA (miRNA) Marketmake the report investor’s guide.

Scope of the Global MicroRNA (miRNA) Market: Inquire beforebuying

 

Global MicroRNA (miRNA) Market, By Research Tools

 

• Services

o Sample collection

 Whole Blood

 Serum

 Plasma

o miRNA cDNA Synthesis

o Profiling & Purification

o Detection

o Functional Studies

 NGS

 Microarray

 Real Time PCR

 Others

• Products

o Instruments

o Consumables

 Isolation & Purification

 Quantification & Detection

 Functional Analysis

 Others

Global MicroRNA (miRNA) Market, By Application

 

• Cancer

• Infectious Diseases

• Immunological Disorder

• Cardiovascular Disease

• Neurological Disease

• Others

Global MicroRNA (miRNA) Market, By End-use

 

• Biotechnology and Pharmaceutical Companies

• Academic & Government Research Institutes

• Others

Global MicroRNA (miRNA) Market, By Region

 

• North America

• Europe

• Asia Pacific

• Middle East & Africa

• South America

Key players operating in the Global MicroRNA (miRNA) Market

 

• Illumina, Inc.

• F. Hoffmann-La Roche Ltd

• Agilent Technologies

• Bio-Rad Laboratories Inc.

• Sigma Aldrich Corp.

• Qiagen N.V

• Thermo Fisher Scientific, Inc.

• HTG Molecular Diagnostics, Inc.

• Bioline GmbH (A Meridian Life Science Company)

• Rosetta Genomics Ltd.

• Dharmacon, a Horizon Discovery Group Co.

• BioVendor — Laboratorní medicína a.s.

• Miltenyi Biotec

• Kaneka Corporation (Eurogentec)

• Abcam Plc

• GeneCopoeia, Inc.

• Promega Corporation

• New England Biolabs, Inc.

• NanoString Technologies, Inc.

• System Biosciences LLC

• Others

For More Information Vist : https://www.maximizemarketresearch.com/market-report/global-microrna-mirna-market/78133/

Report Is Submitted By : Maximize Market Research Company 

Customization of the report: 

Maximize Market Research of reports as per your demand. Thisreport can be personalized to meet your requirements. Get in touch with us andour sales team will guarantee provide you to get a report that suits yournecessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on20,000 high growth emerging opportunities & technologies as well as threatsto the companies across the Healthcare, Pharmaceuticals, Electronics &Communications, Internet of Things, Food and Beverages, Aerospace and Defenseand other manufacturing sectors.